Arthritis, Musculoskeletal and Skin Diseases Research in Tennessee
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $26.2 million to recipients in Tennessee in 44 grants from fiscal 2021 to 2025, 1.0% of the program's national total. Vanderbilt University Medical Center received the most, $14.3 million.
- Awarded in Tennessee$26.2 million
- Awards44
- Share of the program1.0%
- Rank among states22nd of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 17 | $4.3 million |
| FY 2022 | 22 | $6.1 million |
| FY 2023 | 21 | $5.2 million |
| FY 2024 | 17 | $4.7 million |
| FY 2025 | 17 | $5.8 million |
Recipients in Tennessee
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Vanderbilt University Medical Center | Nonprofits | 21 | $14.3 million |
| Vanderbilt University Medical Center | Colleges and universities | 13 | $7.9 million |
| University of Tennessee | Colleges and universities | 4 | $1.3 million |
| Tennessee Technological University | Colleges and universities | 1 | $679,995 |
| St Jude Children's Research Hospital Inc | Nonprofits | 1 | $660,946 |
| University of Tennessee | Colleges and universities | 2 | $542,797 |
| University of Memphis | Colleges and universities | 1 | $408,862 |
| Finally, LLC | Small businesses | 1 | $275,764 |
Open opportunities under this program
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
See all 60 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to Tennessee?
$26.2 million from fiscal 2021 to 2025, across 44 awards. Tennessee ranks 22nd of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in Tennessee?
The largest recipient is Vanderbilt University Medical Center, with $14.3 million in 21 awards. Next are Vanderbilt University Medical Center and University of Tennessee.
Can organizations in Tennessee apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in Tennessee
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Head Start